Frontiers in Endocrinology (Nov 2023)
Association of Cutibacterium acnes with human thyroid cancer
- Vaishakhi Trivedi,
- Vaishakhi Trivedi,
- Vanita Noronha,
- Vanita Noronha,
- Peddagangannagari Sreekanthreddy,
- Sanket Desai,
- Sanket Desai,
- Disha Poojary,
- Linu Varghese,
- Pooja Gowda,
- Ashwin Butle,
- Rohit Mishra,
- Munita Bal,
- Munita Bal,
- Neha Mittal,
- Neha Mittal,
- Swapnil Rane,
- Swapnil Rane,
- Shubhada Kane,
- Sandip Basu,
- Vijay Patil,
- Nandini Menon,
- Ajay Kumar Singh,
- Pankaj Chaturvedi,
- Pankaj Chaturvedi,
- Pratik Chandrani,
- Pratik Chandrani,
- Pratik Chandrani,
- Anuradha Choughule,
- Anuradha Choughule,
- Vidya Veldore,
- Kumar Prabhash,
- Kumar Prabhash,
- Amit Dutt,
- Amit Dutt
Affiliations
- Vaishakhi Trivedi
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Vaishakhi Trivedi
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Vanita Noronha
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Vanita Noronha
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Peddagangannagari Sreekanthreddy
- 4baseCare Oncosolutions Pvt ltd, Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India
- Sanket Desai
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Sanket Desai
- Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India
- Disha Poojary
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Linu Varghese
- 4baseCare Oncosolutions Pvt ltd, Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India
- Pooja Gowda
- 4baseCare Oncosolutions Pvt ltd, Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India
- Ashwin Butle
- Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India
- Rohit Mishra
- Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India
- Munita Bal
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Munita Bal
- Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Neha Mittal
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Neha Mittal
- Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Swapnil Rane
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Swapnil Rane
- Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Shubhada Kane
- Consultant Onco-pathologist, Jaslok Hospital, Mumbai, Maharashtra, India
- Sandip Basu
- Radiation Medicine Centre, Bhabha Atomic Research Centre, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Vijay Patil
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Nandini Menon
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Ajay Kumar Singh
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Pankaj Chaturvedi
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Pankaj Chaturvedi
- Department of Head and Neck Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
- Pratik Chandrani
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Pratik Chandrani
- Medical oncology molecular laboratory, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Pratik Chandrani
- 0Centre for Computational Biology, Bioinformatics and Crosstalk Lab, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India
- Anuradha Choughule
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Anuradha Choughule
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Vidya Veldore
- 4baseCare Oncosolutions Pvt ltd, Institute of Bioinformatics and Applied Biotechnology, Bengaluru, Karnataka, India
- Kumar Prabhash
- Department of Medical Oncology, Tata Memorial Hospital, Mumbai, Maharashtra, India
- Kumar Prabhash
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Amit Dutt
- Homi Bhabha National Institute, Mumbai, Maharashtra, India
- Amit Dutt
- Integrated Cancer Genomics Laboratory, Advanced Centre for Treatment, Research, and Education in Cancer, Navi Mumbai, Maharashtra, India
- DOI
- https://doi.org/10.3389/fendo.2023.1152514
- Journal volume & issue
-
Vol. 14
Abstract
IntroductionThe diverse subtypes of thyroid carcinoma have distinct clinical outcomes despite a comparable spectrum of underlying genetic alterations. Beyond genetic alterations, sparse efforts have been made to characterize the microbes associated with thyroid cancer. In this study, we examine the microbial profile of thyroid cancer.MethodsWe sequenced the whole transcriptome of 70 thyroid cancers (40 papillary and 30 anaplastic). Using Infectious Pathogen Detector IPD 2.0, we analysed the relative abundance of 1060 microbes across 70 tumours from patients with thyroid cancer against 118 tumour samples from patients with breast, cervical, colorectal, and tongue cancer.ResultsOur analysis reveals a significant prevalence of Cutibacterium acnes in 58.6% thyroid cancer samples compared to other cancer types (p=0.00038). Immune cell fraction analysis between thyroid cancer samples with high and low Cutibacterium loads identify enrichment of immunosuppressive cells, including Tregs (p=0.015), and other anti-inflammatory cytokines in the tumour microenvironment, suggesting an immune evasion/immunosuppression milieu is associated with the infection. A higher burden of Cutibacterium acnes was also found to be associated with poor survival defining a distinct sub-group of thyroid cancer.ConclusionCutibacterium acnes is associated with immune suppression and poor prognosis in a subpopulation of thyroid cancer. This study may help design novel therapeutic measures involving appropriate antibiotics to manage the disease better.
Keywords